Executive Medical Director, CardioRenal

Role: Executive Director of Clinical Development in Cardio-Renal diseases, leading strategy, trial execution, and regulatory interactions for Lilly's expanding cardio-renal portfolio. Responsibilities include developing clinical plans, overseeing global trials across phases, ensuring compliance with GCP and regulatory standards, and supporting regulatory submissions and external scientific collaborations. The role involves engaging with external experts, supporting data dissemination, and contributing to business strategies for product commercialization. Qualifications: Medical Doctor or DO, with at least five years of clinical research or drug development experience, preferably with board certification in cardiovascular or renal diseases. Experience in designing and managing large global clinical trials is essential. Preferred skills include additional PhD training, business acumen, and prior leadership in clinical teams. High-value biopharma specifics include focus on cardiovascular and renal indications, early to late-stage clinical trials, regulatory engagement, and cross-functional collaboration across scientific, medical, and commercial teams. The position reports to the SVP of Cardio-Renal Research and Early Clinical Development. Location and travel details are not specified.